艾美捷科技特约代理BioPAL全系列产品。

BioPAL公司位于美国马萨诸塞Worcester，服务于生命科学和生物医药行业，主要从事非放射性报告系统的研发、生产、商业化。此外，BioPAL销售用于核磁共振（MRI）的纳米颗粒；BioPAL还提供即用型的细胞标记及示踪产品。

BioPhysics Assay Laboratory (BioPAL, Inc.) is a privately held, for-profit company based in Worcester Massachusetts. The company develops and sells novel tools for the life science and biomedical communities. BioPAL was the first company to commercialize non-radioactive products that use neutron activation technology as the read-out system. The company also develops and sells nanoparticles for applications in magnetic resonance imaging (MRI), magnetic separation applications and tools for time resolved fluorescent technology. BioPAL offers ready-to-use cell labeling and tracking products for cellular therapy research applications.

BioPAL was the first to introduce functional immunoassay technology (FIT) to the research community. The company offers a line of renal diagnostics based on FIT to measure glomerular filtration rate (GFR) and effective renal blood flow (RBF). Most notably is BioPAL's ELISA kit for the measurement of inulin.

BioPAL公司的主要产品包括：

Pre-Clinical Imaging Agents

Kidney Diagnostics

Microspheres for Blood Flow Studies

Dead-Cell Removal Kits - Viahanc

Products for Cellular Therapy Research

Dendritics公司主要关注人类树突状细胞，希望找到能够促使CD34+造血前体细胞转化为树突状细胞（在GM-CSF和TNF-alpha存在的情况下）的细胞因子。在1992-2005年间，大量的研究使得研究者对人类树突状细胞的产生、细胞通路、C-type凝集素受体的功能及Toll-like受体的活性有了更深的理解。

DENDRITICS was started in 2005 by former members of SCHERING PLOUGH Laboratory for Immunological Research (LIR) in Dardilly, France. From their long experience at LIR, the team members of DENDRITICS have gathered complementary scientific and technological knowledge in different areas of immunology. The initial focus of LIR was in the biology of B lymphocytes, elaboration of human monoclonal antibodies, and in cytokine discovery (IL-3, IL-4, IL-7, IL-10, IL-17, GM-CSF) together with our colleagues of DNAX Research Institute in Palo Alto, California.

Our interest in cytokines led to the finding that human dendritic cells (DCs) could be generated in vitro from CD34+ hematopoietic progenitors cultured in the presence of GM-CSF and TNF-alpha.

The period from 1992 to 2005 saw the specialization of LIR in DC biology and was fuelled by a large-scale effort to discover and study the function of genes specifically expressed by these cells. This program led to a number of findings that contributed in particular to understanding the heterogeneity of DCs, the pathways regulating DC migration, the function of C-type lectin receptors in DCs and the activity of Toll-like receptors in DCs. Many novel genes were discovered through screening of cDNA libraries or through monoclonal antibodies raised against DCs.

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技代理CortecNet品牌全系列产品

CortecNet成立于1995年，是一家以稳定同位素为核心驱动的公司，致力于在 NMR、质谱（MS）、磁共振成像（MRI）和PET领域识别、开发和营销创新产品。这些技术在表征蛋白质、生物分子及材料的结构与动力学，以及在代谢成像应用中发挥着关键作用。CortecNet已与国际领先公司和机构建立了牢固的合作关系，开发了利用大肠杆菌、昆虫细胞、哺乳动物细胞和无细胞表达系统进行稳定同位素标记蛋白表达的创新策略。

▍CortecNet产品线

● NMR &Analytica：聚焦于核磁共振技术相关的应用场景，具体产品包括氚代溶剂、D2O回收等一系列与核磁共振分析相关产品和耗材等。

● Nuclear Medicine & lmaging：核医学和成像领域，具体产品有核医学相关业务、超极化MRI以及氚代谢成像等。

● Industry Applications：具体产品涵盖OLED相关，氚代药物、电子领域、体内研究以及能源领域等。

▍CortecNet部分产品列表